Amlexanox

Amlexanox

SCHEMBL5058549

CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1.CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Amlexanox. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDE4D known ✓ Q08499 1/20 1.00
TBK1 Q9UHD2 20/20 1.00
IKBKE Q14164 12/20 1.00
KDM4E B2RXH2 1/20 1.00
NPC1 O15118 1/20 1.00
ABCC4 O15439 1/20 1.00
TTR P02766 1/20 1.00
GAA P10253 1/20 1.00
PKM P14618 1/20 1.00
ADRA1A P35348 1/20 1.00
OPRD1 P41143 1/20 1.00
RAB9A P51151 1/20 1.00
PDE3A Q14432 1/20 1.00
GPR35 Q9HC97 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amlexanox SCHEMBL29381739 1.00 TBK1 (1.00) TBK1IKBKEKDM4ENPC1ABCC4
Amlexanox SCHEMBL29441547 1.00 TBK1 (1.00) TBK1IKBKEKDM4ENPC1ABCC4
Amlexanox SCHEMBL29642 1.00 TBK1 (1.00) TBK1IKBKEKDM4ENPC1ABCC4
Amlexanox SCHEMBL2907023 0.99 TBK1 (0.98) TBK1IKBKEKDM4ENPC1ABCC4
Amlexanox SCHEMBL2908304 0.99 TBK1 (0.98) TBK1IKBKEKDM4ENPC1ABCC4
Amlexanox SCHEMBL2902814 0.99 TBK1 (0.98) TBK1IKBKEKDM4ENPC1ABCC4
Amlexanox SCHEMBL16216144 0.93 TBK1 (0.87) TBK1IKBKEKDM4ENPC1ABCC4
SCHEMBL19180152 0.91 TBK1 (1.00) TBK1IKBKEKDM4ENPC1ABCC4
Amlexanox SCHEMBL16216162 0.90 TBK1 (0.82) TBK1IKBKEKDM4ENPC1ABCC4
SCHEMBL19197522 0.90 TBK1 (0.81) TBK1IKBKEKDM4ENPC1ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3137065-A2 COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES Pharnext (FR) 2017-03-08 EP disclosed
WO-2015165948-A2 COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES PHARNEXT (FR) 2015-11-05 WO disclosed
EP-2892518-A2 NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE Pharnext (FR) 2015-07-15 EP disclosed
WO-2014037416-A2 NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE PHARNEXT (FR) 2014-03-13 WO disclosed
EP-1931760-A2 MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS The University of Alabama (US) 2008-06-18 EP disclosed
WO-2007044693-A2 MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS THE UNIVERSITY OF ALABAMA (US) 2007-04-19 WO disclosed